Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT05494190

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

Led by Eye & ENT Hospital of Fudan University · Updated on 2025-12-30

111

Participants Needed

3

Research Sites

260 weeks

Total Duration

On this page

Sponsors

E

Eye & ENT Hospital of Fudan University

Lead Sponsor

S

Shandong Provincial Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a multi-center, multidisciplinary, open-label, randomized controlled prospective clinical study.

CONDITIONS

Official Title

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Able to understand and willing to sign informed consent
  • Age between 18 and 75 years
  • Male or female
  • Karnofsky physical status (KPS) of 80 or higher
  • Adequate liver, kidney, and blood function based on specified lab limits
  • Diagnosed with squamous cell carcinoma of the hypopharynx
  • Clinical stage T1/2 N2/3 M0 according to AJCC 8th edition
  • Resectable regional metastatic lesion
  • Tumor lesions assessable by RECIST version 1.1
  • Intent to receive radical treatment
  • Use of contraceptive methods during study and for 6 months after last cisplatin dose if fertility and pregnancy risk present
  • Good treatment compliance
Not Eligible

You will not qualify if you...

  • Presence of distant metastatic disease
  • History of other cancers or second primary tumor
  • Previous treatment for primary tumor except biopsy
  • Participation in other clinical trials within 1 month
  • Poor tolerance expected for induction chemotherapy
  • Severe acute or chronic medical conditions or mental illness deemed inappropriate for trial participation
  • Intent for palliative treatment
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Harbin Medical University Cancer Hospital

Harbin, Heilongjiang, China, 150000

Not Yet Recruiting

2

Shandong Provincial ENT Hospital, Cheeloo College of Medicine, Shandong University

Jinan, Shandong, China, 250012

Not Yet Recruiting

3

Eye & ENT Hospital, Fudan University

Shanghai, Shanghai Municipality, China, 200031

Actively Recruiting

Loading map...

Research Team

F

Feiran Li

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here